Vincent P. Ippolito, EVP & Chief Commercial Officer at Anacor Pharmaceuticals, Inc. (ANAC), sold 9,000 shares at $64.88 ($575K) on 2016-03-02, disclosed to the SEC on 2016-03-04.
Open-market sale of $575k ANAC by EVP & Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.23 | 1,600 | $100K | 17.3% |
| 2 | $63.56 | 1,875 | $119K | 20.7% |
| 3 | $64.22 | 3,696 | $237K | 41.3% |
| 4 | $64.88 | 1,829 | $119K | 20.6% |
| Total | $63.86 avg | 9,000 | $575K | 100% |
| Filing → |
| ANAC | SELL | 2016-01-21 | $1.9M | — | Filing → |
| ANAC | SELL | 2016-01-21 | $1.9M | — | Filing → |
| ANAC | SELL | 2016-01-05 | $62K | — | Filing → |